|
| |
Boston ScientificBoston Scientific Corporation (NYSE: BSX) is the world's largest medical device company dedicated to less-invasive therapies. The Company's products and technologies are designed to reduce risk, trauma, cost, procedure time and the need for aftercare.These products and technologies are generally used for enlarging narrowed blood vessels to prevent heart attack and stroke, clearing passages blocked by plaque to alleviate pain, opening obstructions and bringing relief to patients suffering from various forms of cancer, performing biopsies and ultrasounds, mapping electrical problems in the heart, placing filters to prevent blood clots from reaching the lungs, heart or brain, and treating urological, renal, pulmonary, cerebrovascular and gastrointestinal diseases. These less-invasive therapies are designed to improve outcomes in order to help patients return to fuller lives sooner
| Contact Details: |
| One Boston Scientific Place |
| Natick |
| |
| 01760-1537 |
| United States of America |
| Tel: | 508 650 8000 |
| Fax: | |
| Email: | |
| WWW: | www.bostonscientific.com/
|
| |
Recent Publications by Boston Scientific: |  |
Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations.
The controlled release of paclitaxel (PTx) from stent coatings comprising... | 17th September, 2009
| Corporate Research and Advanced Technology, Boston Scientific Corporation,
| J Biomed Mater Res A. 2009 Aug;90(2):522-32.
DOI Direct Link |
In vitro and in vivo evaluation of the safety and stability of the TAXUS Paclitaxel-Eluting Coronary Stent.
Functional aspects of the styrene-b-isobutylene-b-styrene triblock... | 21st August, 2009
| Boston Scientific Corporation, One Boston Scientific Place, Natick, MA
| J Mater Sci Mater Med. 2009 Jul;20(7):1553-62. Epub 2009 Mar 4.
DOI Direct Link |
Development of a new niobium-based alloy for vascular stent applications.
This study was performed in order to develop a new stent material that... | 20th August, 2009
| Boston Scientific Corporation, Ballybrit Business Park, Galway, Ireland.
| J Mech Behav Biomed Mater. 2008 Oct;1(4):303-12. Epub 2007 Nov 17.
DOI Direct Link |
Characterisation of atherosclerotic plaque by spectral similarity of radiofrequency intravascular ultrasound signals.
AIMS: The aim of this paper is to report a method of atherosclerotic... | 25th July, 2009
| Boston Scientific
| EuroIntervention. 2009 May;5(1):133-9.
|
In vivo and in vitro characterization of poly(styrene-b-isobutylene-b-styrene) copolymer stent coatings for biostability, vascular compatibility and mechanical integrity.
The TAXUS(R) Express (2)Paclitaxel Eluting Coronary Stent System employs a... | 11th March, 2009
| Boston Scientific Corporation, One Boston Scientific Place, Natick,
| J Biomed Mater Res A. 2009 Mar 9.
DOI Direct Link |
→View more Boston Scientific research publications. |
Press Releases on Boston Scientific:
|
 |
| Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent |
20th November, 2009 |
Boston Scientific Corporation |
NATICK, Mass. and LONDON, Nov. 20 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration
|
| Reportlinker Adds Cardiovascular Catheters and Systems - Global Market Opportunities |
18th November, 2009 |
Reportlinker |
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Cardiovascular Catheters and Systems - Global Market Opportunities
http:/
|
| Reportlinker Adds Drug-Eluting Stents - Global Market Opportunities |
18th November, 2009 |
Reportlinker |
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Drug-Eluting Stents - Global Market Opportunities
http://www.reportlinker
|
| American Heart Association Late-breaking Clinical Trial Report: Risks of Anemia Drug Outweigh Benefits in Cardiovascular Disease Patients With Diabetes and Kidney Disease |
16th November, 2009 |
American Heart Association |
Study highlights:
- Risks of an anemia drug appear to outweigh its benefits among diabetic patients with kidney disease, anemia and a history of cardiovascular disease or stroke.
- This first large,
|
| Reportlinker Adds United States Medical Equipment Market Analysis & Forecasts to 2015 |
10th November, 2009 |
Reportlinker |
NEW YORK, Nov. 10 /PRNewswire/ --
Reportlinker.com announces that a new market research report is available in its catalogue.
United States Medical Equipment Market Analysis & Forecasts to 2015
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 463 times since April 2007, the link to the organisation's website has been followed 64 times Recent Search Terms used to find this page: boston scientific niobium alloy stent | boston scientific neuromodulation problems | Boston Sceintific Neuro | medical company with patent on new stent in August 2009 | boston scientific - press release - july 09 | email boston scientific | styrene isobutylene catheter | boston scientific neuro HR contact | Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations | . Search for more companies in Natick Search for more companies in This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Boston Scientific |
